RIZATRIPTAN N-OXIDE (25 mg) (2-{5-[(1H-1,2,4-Triazol-1-yl)methyl]-1H-indol-3-yl}-N,N-dimethylethanamine oxide)

In Stock

Ready to ship

Catalogue No.

1A10040

CAS No.

260435-42-5

Molecular Formula

C₁₅H₁₉N₅O

Product Type

Pharmaceutical Analytical Impurities

$750.00

Shipping information

Click Here to learn more about Pharmaceutical Analytical Impurities (PAI). PAI products are different from official USP Reference Standards. This material is an Analytical Material and not a USP Reference Standard.

Additional information

Additional information

Current Lot Information

Current Lot:

F246U0

Harmonized System (HS) Code *:

29339910

UN No:

N/A

NDC No:

N/A

Molecular Formula

C₁₅H₁₉N₅O

Container Type:

VIAL

Base Control Substance (substance %):

N | A

Product Information

SDS:

USP Certificates/Product Information Sheets and Valid Use Dates

Lot No	USP Certificates/Product Information Sheets and Valid Use Dates	Valid Use Date	Country of Origin*	Material Origin*
F246U0	1A10040-F246U0	See Product Information Sheet	India	Chemical Synthesis


Lot No F246U0	USP Certificates/Product Information Sheets and Valid Use Dates Chemical Synthesis
Valid Use Date See Product Information Sheet
Country of Origin* India
Material Origin* No data available

Lot No

F246U0

USP Certificates/Product Information Sheets and Valid Use Dates

Chemical Synthesis

Valid Use Date

See Product Information Sheet

Country of Origin*

India

Material Origin*

No data available

Frequently bought together

RIZATRIPTAN N-OXIDE (25 mg) (2-{5-[(1H-1,2,4-Triazol-1-yl)methyl]-1H-indol-3-yl}-N,N-dimethylethanamine oxide)

Catalogue No.

1A10040

CAS No.

260435-42-5

Molecular Formula

C₁₅H₁₉N₅O

Product Type

Pharmaceutical Analytical Impurities

$750.00

INDOMETHACIN HYDRAZINE ANALOG (25 mg) (1-(4-Chlorobenzoyl)-1-(4-methoxyphenyl)-2-(4-chlorobenzoyl)hydrazide)

Catalogue No.

1A10010

CAS No.

402849-27-8

Molecular Formula

C₂₁H₁₆Cl₂N₂O₃

Product Type

Pharmaceutical Analytical Impurities

$450.00

EPOXY BETAMETHASONE (25 mg) (9,11β-Epoxy-17,21-dihydroxy-16β-methyl-9β-pregna-1,4-diene-3,20-dione)

Catalogue No.

1A10160

CAS No.

981-34-0

Molecular Formula

C₂₂H₂₈O₅

Product Type

Pharmaceutical Analytical Impurities

$950.00

GUANOSINE (25 mg) (2-Amino-9-β-D-ribofuranosylpurine-6(1H)-one)

1-HYDROXY-2-NAPHTHOIC ACID (25 mg) (1-Hydroxy-naphthalene-2-carboxylic acid)

DIDEHYDROGLYCOPYRROLATE (25 mg) (3-[2-(Cyclopent-1-en-1-yl)-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidin-1-ium bromide)

PIVALOYL PHENYLGLYCINE (25 mg) ((R)-2-Phenyl-2-pivalamidoacetic acid)

SULFAGUANIDINE (25 mg) (4-Amino-N-carbamimidoylbenzenesulfonamide)

17α-HYDROXYPROGESTERONE (25 mg) (17-Hydroxypregn-4-ene-3,20-dione)

EPOXY BETAMETHASONE (25 mg) (9,11β-Epoxy-17,21-dihydroxy-16β-methyl-9β-pregna-1,4-diene-3,20-dione)

DIMETHYL FELODIPINE (25 mg) (Dimethyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate)

DESCHLORO DESLORATADINE HYDROCHLORIDE (25 mg) (6,11-Dihydro-11-(piperidin-4-ylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine hydrochloride)

O-ACETYL IOPAMIDOL (25 mg) ((S)-5-[[2-(acetyloxy)-1-oxopropyl]amino]-N,N′-bis[2-hydroxy-1-(hydroxymethyl)ethyl]-2,4,6-triiodo-1,3-Benzenedicarboxamide)